Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulation
- 4 January 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 314 (1) , 186-191
- https://doi.org/10.1016/j.bbrc.2003.12.074
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- c-Jun N-terminal Kinase Contributes to Apoptotic Synergy Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand plus DNA Damage in Chemoresistant, p53 Inactive Mesothelioma CellsPublished by Elsevier ,2003
- Predictive and prognostic factors in malignant pleural mesotheliomaCurrent Opinion in Oncology, 2003
- Chemotherapy for malignant pleural mesothelioma: past results and recent developmentsBritish Journal of Cancer, 2003
- Apo2L/TRAIL and its death and decoy receptorsCell Death & Differentiation, 2003
- Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesotheliomaCarcinogenesis: Integrative Cancer Research, 2002
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancerNature Reviews Drug Discovery, 2002
- Defining Characteristics of Types I and II Apoptotic Cells in Response to TRAILNeoplasia, 2002
- Rel/NF-κB Transcription Factors Protect against Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Up-regulating the TRAIL Decoy Receptor DcR1Journal of Biological Chemistry, 2001
- Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand and Chemotherapy Cooperate to Induce Apoptosis in Mesothelioma Cell LinesAmerican Journal of Respiratory Cell and Molecular Biology, 2001
- Apoptosis control by death and decoy receptorsPublished by Elsevier ,1999